Combination of targeted therapy and immune checkpoint blocker in a patient with xeroderma pigmentosum presenting an aggressive angiosarcoma and a recurrent non-resectable basal cell carcinoma.

Celine Boutros Etienne Rouleau Michael Majer Sergei Nikolaev Caroline Robert

Eur J Cancer

Dermatology Unit, Gustave Roussy Cancer Campus, Villejuif, France; Inserm U981, Gustave Roussy Cancer Campus, Villejuif, France; University Paris-Saclay, Faculty of Medicine, Kremlin-Bicêtre, France. Electronic address:

Published: June 2021

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.ejca.2021.03.022	DOI Listing

Publication Analysis

Top Keywords

combination targeted

targeted therapy

therapy immune

immune checkpoint

checkpoint blocker

blocker patient

patient xeroderma

xeroderma pigmentosum

pigmentosum presenting

presenting aggressive

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!